about
Evidence of ROS generation by mitochondria in cells with impaired electron transport chain and mitochondrial DNA damage.Heparin-induced thrombocytopenia associated with intra-tumour haemorrhage in cavernous sinus after cardiac myxoma surgery.Interference of Co-amplified nuclear mitochondrial DNA sequences on the determination of human mtDNA heteroplasmy by Using the SURVEYOR nuclease and the WAVE HS systemA mitochondrial superoxide theory for oxidative stress diseases and agingChasing great paths of Helmut Sies "Oxidative Stress".Analytical variables affecting analysis of F2-isoprostanes and F4-neuroprostanes in human cerebrospinal fluid by gas chromatography/mass spectrometry.Mitochondria as possible pharmaceutical targets for the effects of vitamin E and its homologues in oxidative stress-related diseases.Unresolved issues in the analysis of F2-isoprostanes, F4-neuroprostanes, isofurans, neurofurans, and F2-dihomo-isoprostanes in body fluids and tissue using gas chromatography/negative-ion chemical-ionization mass spectrometry.Suppression of coenzyme Q₁₀ levels and the induction of multiple PDSS and COQ genes in human cells following oligomycin treatment.Roles of mitochondria-generated reactive oxygen species on X-ray-induced apoptosis in a human hepatocellular carcinoma cell line, HLE.Effect of mitochondrial dysfunction and oxidative stress on endogenous levels of coenzyme Q(10) in human cells.Enhancement of cisplatin-induced apoptosis and caspase 3 activation by depletion of mitochondrial DNA in a human osteosarcoma cell line.Increase of lipid peroxidation by cisplatin in WI38 cells but not in SV40-transformed WI38 cells.Impurities from polypropylene microcentrifuge tubes as a potential source of interference in simultaneous analysis of multiple lipid-soluble antioxidants by HPLC with electrochemical detection.Correlation of F4-neuroprostanes levels in cerebrospinal fluid with outcome of aneurysmal subarachnoid hemorrhage in humans.Vitamin E suppresses enhancement of factor VIII-dependent thrombin generation by systemic hypoxia.Prognostic factors of spontaneous intracerebral haemorrhage in haemodialysis patients and predictors of 30-day mortality.Levels of F2-isoprostanes, F4-neuroprostanes, and total nitrate/nitrite in plasma and cerebrospinal fluid of patients with traumatic brain injury.Disruption of the human COQ5-containing protein complex is associated with diminished coenzyme Q10 levels under two different conditions of mitochondrial energy deficiency.Cerebrospinal fluid biomarkers for neuropsychological symptoms in early stage of late-onset Alzheimer's disease.Tamoxifen protects against acute tumor necrosis factor alpha-induced cardiac injury via improving mitochondrial functions.Protective effect of indigo naturalis extract against oxidative stress in cultured human keratinocytesIncreased levels of F2-isoprostanes following aneurysmal subarachnoid hemorrhage in humansAdvantages and considerations in the confirmation of mitochondrial DNA mutations by denaturing HPLC and pyrosequencingAlterations of the levels of primary antioxidant enzymes in different grades of human astrocytoma tissues
P50
Q33274385-A854D1CD-D1F0-48CA-822E-8C42D86D28B0Q33383397-60423AC9-8A37-4EDB-95E9-0C807B520285Q34411819-64D7AD5E-C756-46F9-AF2C-D58C03682310Q35014145-8B4AB2BB-C706-4D32-88EA-0B21D9E0CF06Q35994332-12A58D7F-4AF9-47C1-A0CC-252965FBCDACQ37055201-C2FD5E10-4B41-4A09-BB31-3B5F93254CC2Q37903067-5D1D56E0-7269-43C0-928D-442C4EC43199Q38392133-A07986FB-518F-4641-AD39-8A74F2402BDDQ38977377-75126A83-C1A6-4D6E-BE2B-19CCC236CD64Q39338541-4247723C-0E3B-4F10-8178-EA5682692CC6Q39594821-2D242111-6D08-4543-BB81-EF6A71612850Q40407402-4E435E9E-534B-467B-B78F-BE975492F094Q40666654-459A22EE-17B9-474E-9691-D22C96C7C555Q44898634-2C861235-DA0D-4633-8063-197C10AFD135Q45952881-11A56D83-F49B-4B74-A890-56D04FAE55C1Q46299769-B27FA985-D2D3-41DC-A6BA-99BCE02DE835Q46889700-9044DAB2-B72E-47A0-9B8C-881C55ED9732Q47664165-C49EB58D-BB0D-4A65-A967-C0A3B9104553Q50202181-2683D997-8564-4AD5-8E0C-AF3DF188E4F3Q50619019-545AEF1A-BC5F-4961-AB0A-57EA33001C68Q51814839-63FB4A3E-2955-4CA5-92B5-D3B71A3318FDQ83163410-3E89F489-B28B-41AD-A4D1-B9887586D950Q83187689-D29B688F-515A-4FA5-9887-2789A2E683AEQ84585045-CD8B1BC1-562B-4FCC-8407-13AA8F6C2025Q88969953-B2D6E275-6799-4FE7-8A3E-49D090D61E90
P50
description
onderzoeker
@nl
researcher, ORCID id # 0000-0002-9951-2000
@en
name
Hsiu-Chuan Yen
@ast
Hsiu-Chuan Yen
@en
Hsiu-Chuan Yen
@es
Hsiu-Chuan Yen
@nl
type
label
Hsiu-Chuan Yen
@ast
Hsiu-Chuan Yen
@en
Hsiu-Chuan Yen
@es
Hsiu-Chuan Yen
@nl
prefLabel
Hsiu-Chuan Yen
@ast
Hsiu-Chuan Yen
@en
Hsiu-Chuan Yen
@es
Hsiu-Chuan Yen
@nl
P106
P31
P496
0000-0002-9951-2000